TKMS's One-Two Punch: US Roadshow Meets a June of Mega-Deals

The defence contractor is juggling two high-stakes campaigns this month: a charm offensive with American investors in New York and Boston, and a pair of multibillion-dollar decisions in Canada and Berlin that could reshape its order book. The stock, after sliding to €75.20, is under pressure, but the potential prize is enormous.

Stock swings and a window of opportunity

TKMS shares have been on a rollercoaster since their January peak of €102.90. After closing at €76.70 following the roadshow's first day, the stock slipped another nearly 2% to €75.20. The gap to the 50-day moving average of €81.28 has widened, and the Relative Strength Index has dropped from 44 to 41.6 — a neutral reading that suggests selling is losing steam. With annualised 30-day volatility hovering around 49%, the shares remain a wild ride for traders.

Two titanic contracts on the table

The most immediate catalyst is Ottawa's long-awaited decision on a new submarine fleet. Canada is shopping for up to twelve conventional boats of the 212CD class, with a total programme value of €37 billion. TKMS is pitted against a South Korean consortium led by Hanwha Ocean, and a verdict is expected before the end of June. The German outfit has tried to sweeten its bid by teaming up with Isar Aerospace, the Munich-based rocket builder that just closed a €270 million funding round. Together they plan to offer Canada a combined package of maritime subs and satellite-launch infrastructure — a pitch that could tip the scales.

Simultaneously, back in Germany, the Bundestag's budget committee is set to vote on 24 June on a new frigate programme. The first tranche alone is worth around €26 billion, and TKMS is the sole remaining bidder. Only its in-house design can integrate the required Aegis combat systems. If it wins, the company's current order backlog of roughly €20 billion would double overnight.

Should investors sell immediately? Or is it worth buying TKMS?

Financial reality check

Behind the headline backlog, the half-year numbers tell a more nuanced story. Revenue rose 10% to about €1.17 billion in the first six months of fiscal 2025/26, while adjusted EBIT climbed 14% to €60 million, lifting the margin to 5.1%. Management has reaffirmed its full-year guidance: 2% to 5% sales growth and an adjusted EBIT margin above 6%. Over the medium term, TKMS aims for around 10% average annual revenue growth and a margin north of 7%.

Yet the cash flow picture is less rosy. Free cash flow came in at minus €72 million for the half, a sharp reversal from the prior year's €756 million, which was inflated by a one-off from large advance payments. This shortfall is likely to feature prominently in investor discussions during the US roadshow.

A make-or-break month

The roadshow itself is the company's first major investor pitch since its IPO less than eight months ago. Executives are in New York and Boston this week to sell the growth story: a record backlog, confirmed guidance, and a share price that has retreated roughly a quarter from its January high. Whether that story sticks will become clearer after the trading sessions that follow.

TKMS at a turning point? This analysis reveals what investors need to know now.

But the real judgment call will come from Ottawa and Berlin. If TKMS secures at least one of the two megadeals in June, the fundamental valuation of the group changes immediately. If not, the stock's current woes may persist. Either way, the next few weeks will define the trajectory of this defence champion for years to come.

Ad

TKMS Stock: New Analysis - 9 June

Fresh TKMS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated TKMS analysis...

en | DE000TKMS001 | TKMSS | boerse | 69507445 |